A.I. In Medicine
WORCESTER MEDICINE
As I See It Continued AI in ways that increase health equity and ensure that the application of these technologies supports the patient-provider connection, enhances our interprofessional engagement and relationships, removes bias, and ensures that we are serving all populations of patients with ethical advocacy. + Sonia Nagy Chimienti, MD FIDSA, Senior Associate Dean for Medical Education Dartmouth’s Geisel School of Medicine *IAMSE Fall 2023 Webcast Audio Seminar Series 1. “An Introduction to Artificial Intelligence and Machine Learning with Applications in Healthcare”, presented by H. Valafar, University of South Carolina 2. “Artificial Intelligence: Preparing for the Next Paradigm Shift in Medical Education”, presented by C. James and E. Otles, University of Michigan 3. “Transforming Healthcare Together: Empowering Health Professionals to Address Bias in the Rapidly Evolving AI-Driven Landscape”, presented by S. Bessias, Duke University School of Medicine, and M.P. Cary Jr, Duke School of Nursing 4. “AI Tools for Medical Educators”, V. Capaldi, D. Kurzweil, and E. Steinbach, Uniformed Services University of the Health Sciences 5. “ChatGPT and Other AI Tools for Medicine and Medical Education”, presented by B. Hersh, Oregon Health & Science University.
Compassionate addiction treatment close to home. If you or a loved one is struggling with addiction, contact an AdCare Hospital representative at
1-800-ALCOHOL
24
Winter 2023
LEGAL CONSULT: Financial Transparency Comes Close to Home Peter J. Martin, Esq. Aastha Sharma, Esq.
W
e live in an era rife with reports of financial skullduggery—from the Panama Papers, through Bernie Madoff and now the FTX revelations—where money laundering, fraud, and other forms of criminal behavior have led to much outrage and some regulation. For the most part, the response has been to impose greater levels of transparency on the “malefactors of great wealth.” For small and medium-sized enterprises, including medical and other health care practices, these efforts have been of some interest but of little practical import. Not anymore. The new Corporate Transparency Act (CTA) and its accompanying regulations will impose ownership disclosure obligations on even the smallest practices, beginning January 1, 2024. Owners of these practices can be forgiven if they greet this news with less than overwhelming enthusiasm, but as a practical matter the new requirements are not onerous. However, the penalties for non-compliance are severe and there are nuances that may make compliance difficult in some circumstances. Basically, the CTA requires most privately owned corporations, LLCs and other entities, to file a Beneficial Ownership Interest, or “BOI Report” with the Financial Crimes Enforcement Network (“FinCEN”) of the U. S. Department of the Treasury which includes certain information about the entity’s “beneficial owners.” Beneficial owners include persons who hold at least 25% of the ownership interests in the organization, or who otherwise exercise “substantial control” over the entity. The information to be provided about each beneficial owner is the individual’s name, date of birth, residential or business address, and an identification number from a source such as a driver’s license. There are a number of exemptions, which if applicable, will provide the entity respite from having to file the BOI Report. However, most of the exemptions are for entities that file reports with the Securities and Exchange Commission (SEC) or other regulatory authorities such as publicly traded companies, banks, credit unions, money services
